Log in

CNSX:VPVodis Pharmaceuticals Stock Price, Forecast & News

$0.04
0.00 (0.00 %)
(As of 06/3/2020 02:38 AM ET)
Add
Compare
Today's Range
$0.05
Now: $0.05
$0.05
50-Day Range
$0.03
MA: $0.03
$0.05
52-Week Range
$0.16
Now: $0.05
$0.62
Volume40,000 shs
Average Volume1,714 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone778-990-8985

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive VP News and Ratings via Email

Sign-up to receive the latest news and ratings for VP and its competitors with MarketBeat's FREE daily newsletter.

Vodis Pharmaceuticals (CNSX:VP) Frequently Asked Questions

Has Vodis Pharmaceuticals been receiving favorable news coverage?

News coverage about VP stock has been trending negative this week, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Vodis Pharmaceuticals earned a daily sentiment score of -2.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news aboutVodis Pharmaceuticals.

Who are some of Vodis Pharmaceuticals' key competitors?

What other stocks do shareholders of Vodis Pharmaceuticals own?

Who are Vodis Pharmaceuticals' key executives?

Vodis Pharmaceuticals' management team includes the following people:
  • Mr. Brian R. Gusko, Advisor (Age 52)
  • Mr. Mark Lotz B.B.A., C.A., CPA, Interim CEO, CFO & Director

What is Vodis Pharmaceuticals' stock symbol?

Vodis Pharmaceuticals trades on the CNSX under the ticker symbol "VP."

How do I buy shares of Vodis Pharmaceuticals?

Shares of VP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vodis Pharmaceuticals' stock price today?

One share of VP stock can currently be purchased for approximately $0.05.

What is Vodis Pharmaceuticals' official website?

The official website for Vodis Pharmaceuticals is vodis.ca.

How can I contact Vodis Pharmaceuticals?

The company can be reached via phone at 778-990-8985.

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.